4//SEC Filing
Flynn Daniel Lee 4
Accession 0001209191-23-038753
CIK 0001654151other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:05 PM ET
Size
7.2 KB
Accession
0001209191-23-038753
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-06-16$14.40/sh−1,655$23,835→ 57,158 total
Holdings
- 91,020(indirect: By Trust)
Common Stock
- 180,947(indirect: By Trust)
Common Stock
- 49,488(indirect: By GRAT)
Common Stock
Footnotes (2)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
- [F2]Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001713712
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:05 PM ET
- Size
- 7.2 KB